SkylineDx’s Merlin Test Shows Predictive Accuracy in Early-Stage Melanoma

By Karen Roman SkylineDx said its Merlin CP-GEP molecular test identifies a subset of T1a melanoma patients with sentinel ...

Merlin CP-GEP™ Demonstrates Superior Predictive Accuracy for Sentinel Lymph Node Metastasis in Early-Stage Melanoma

SkylineDx today announced the publication of new data by Dr. Wesley Yu, et al ²., demonstrating that Merlin CP-GEP identifies ...
Yahoo

SkylineDx’s Merlin Test Recognized by NCCN for Melanoma

SkylineDx said its Merlin CP-GEP molecular test is uniquely recognized by the National Comprehensive Cancer Network (NCCN) for predictive use in select T1 and T2 melanoma patients. The test provides ...
Healio

Speaker discusses predictive power of Merlin test for low-, high-risk melanoma

Please provide your email address to receive an email when new articles are posted on . The Merlin test, a clinical-pathologic and gene expression profile, was able to successfully classify 37% of ...